Business Wire

HanseWerk Natur Chooses INNIO to Bring Highly Efficient and Highly Flexible CHP Plant Online

Share

In Germany, renewable energy already makes up more than 40% of electricity consumption. Against this dynamic energy policy backdrop, utility company HanseWerk Natur GmbH and gas engine manufacturer INNIO Jenbacher* have today announced that a further “green” natural-gas combined heat and power (CHP) plant has been commissioned at the existing district heating plant in Wahlstedt, Segeberg, in Schleswig-Holstein.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191122005268/en/

(left to right) Carlos Lange, Matthias Bonse, Dr. Gerta Gerdes-Stolzke and Horst Kornelius formally commission the new CHP plant in Wahlstedt, Segeberg, in Schleswig-Holstein. Copyright: HanseWerk Natur

(left to right) Carlos Lange, Matthias Bonse, Dr. Gerta Gerdes-Stolzke and Horst Kornelius formally commission the new CHP plant in Wahlstedt, Segeberg, in Schleswig-Holstein. Copyright: HanseWerk Natur

The start of operations at the new natural gas-powered CHP plant, which has an output of 4.5 megawatts (MW), sees the total electrical output of the Wahlstedt energy facility climb to up to 7 MW. Consequently, more than 10,000 households can be supplied with power in the Segeberg district. In addition, waste heat recovered within the CHP plant is fed into the region’s district heating network, thereby delivering heat and hot water to as many as 2,300 residential properties and businesses.

“The overall efficiency of the new natural gas-powered CHP plant of more than 92% as well as its high operational flexibility help make the energy supply in Wahlstedt substantially more reliable. The plant thus represents another valuable component in the decentralized supply of energy in the state of Schleswig-Holstein,” explained Dr. Gerta Gerdes-Stolzke, Managing Director of HanseWerk Natur GmbH, at the time of commissioning.

The Wahlstedt facility already has two Jenbacher biogas CHP plants as well as a biomethane CHP system. The commissioning of the new Jenbacher J624 gas engine at the start of the new heating season means that an existing boiler can be taken out of normal operations. Furthermore, the J624 engine’s short startup time of under five minutes allows peaks in electricity demand to be covered quickly and flexibly. For HanseWerk Natur, the investment increases the operating efficiency of the plant while at the same time reducing carbon dioxide emissions.

Carlos Lange, President and CEO of INNIO, said: “With our Jenbacher gas engine technology, we are an integral part of the energy transition. Thanks to the high operational flexibility, our engines are an excellent complement to volatile wind and solar energy. In addition, more than 55% of our currently installed CHP fleet in Germany runs on renewable gases such as biogas and biomethane.”

The new CHP plant in Wahlstedt represents another important milestone in the collaboration between the Northern German utility company and INNIO Jenbacher, a partnership which has lasted over 20 years. A total of more than 70 climate-friendly Jenbacher gas engines are now in use in HanseWerk Natur power plants. In 2011, HanseWerk Natur became a certified service partner for INNIO Jenbacher gas engines in Germany, demonstrating the company’s expertise in this area of technology.

* Indicates a registered trademark

About HanseWerk Natur GmbH

HanseWerk Natur GmbH is one of the largest regional providers of heat and decentralized energy solutions in Northern Germany. The company’s local and district heating networks extend across approximately 500 miles (800 kilometers). With 1,200 heat connection networks, heating plants, as well as combined heat and power plants, HanseWerk Natur supplies several tens of thousands of domestic and business customers in addition to public sector facilities. Furthermore, the company offers tailored energy concepts and advanced power plant technology for optimized energy use that lowers emissions and reduces environmental impact. HanseWerk Natur also operates several high-efficiency CHP plants and a virtual power plant for the procurement of balancing energy. In addition, the company transfers excess heat into its grids as a means of storage for its customers.

About INNIO

INNIO is a leading solutions provider of gas engines, power equipment, a digital platform and related services for power generation and gas compression at or near the point of use. With our Jenbacher and Waukesha product brands, INNIO pushes beyond the possible and looks boldly toward tomorrow. Our diverse portfolio of reliable, economical and sustainable industrial gas engines generates 200 kW to 10 MW of power for numerous industries globally. We can provide life cycle support to the more than 50,000 delivered gas engines worldwide. And, backed by our service network in more than 100 countries, INNIO connects with you locally for rapid response to your service needs.

Headquartered in Jenbach, Austria, the business also has primary operations in Welland, Ontario, Canada, and Waukesha, Wisconsin, US. For more information, visit the company's website at www.innio.com. Follow INNIO on Twitter and LinkedIn.

Contact information

Susanne Reichelt
INNIO
+43 664 80833 2382
susanne.reichelt@innio.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

HighRes Biosolutions and Novo Nordisk partner to transform drug discovery in automated Lab of the Future24.1.2020 17:00:00 EETPress release

HighRes Biosolutions and Novo Nordisk A/S today announced that they will collaborate to design a state-of-the-art robotic platform for high-throughput biologics engineering and characterisation. The integration of a multi-system robotics platform with sophisticated software control architecture will enable a digital transformation and accelerated discovery for Novo Nordisk’s peptide and large molecule therapeutics research. “In order to maintain our leadership within biologics engineering we are investing in a fully automated and digital design platform. This investment is linked to our build-up in AI and advanced analytics and demonstrates Novo Nordisk’s commitment as a world leading biologics research company,” said Lars Fogh Iversen, senior vice president, Global Research Technologies, Novo Nordisk. The platform will comprise several highly automated and integrated cells for production, characterisation and functional analysis of thousands of biologic compounds every month. Its scop

Conquest Invests in 5 Greenfield Onshore Wind Parks Totalizing 43MW in the Flanders Region24.1.2020 15:37:00 EETPress release

Conquest, acting through the Conquest Sustainable Infrastructure fund, announced the transaction was closed after an exclusive agreement had been reached with ENGIE Electrabel. Conquest acquires 51% of a portfolio expected to provide 111 GWh per annum of renewable power representing the annual electricity consumption of about 32,000 Belgian homes from early 2021 onwards. The projects benefit from 15 to 20-year green certificates local remuneration schemes, and thus generate yearly secured revenues. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005221/en/ Credit: Electrabel While the energy and digital transitions continue to drive the infrastructure sector, Conquest keeps building its diversified sustainable real asset portfolio in Western European markets. The success lies in years of collaboration and long-lasting partnerships with fellow industry experts who can notably facilitate access to new growth opportunities

Fluence Expands EMEA Footprint with Horticulture Partners in Papenburg, Germany24.1.2020 14:00:00 EETPress release

Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and agriculture production, announced today it is expanding its presence in the Emsland region of Germany through partnerships with growers and other horticulture specialists operating out of Papenburg. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005109/en/ Friedrich Schulz’s 5.5 hectare farm—which grows herbs year-round in addition to lettuce, peppers and chives—utilizing VYPR 2p fixtures. (Photo: Business Wire) Given Papenburg’s decades-long history of attracting horticulture experts, Fluence’s innovative lighting solutions for horticulture are a natural fit for the region’s tomato, cucumber, leafy greens and herb growers. Forging connections with Papenburg’s horticultural leaders Elektro Evers, an engineering firm specializing in greenhouse technology, is Fluence’s exclusive systems integrator

HCL Technologies Honors Global Goodwill Champions at the 2020 World Economic Forum in Davos24.1.2020 12:47:00 EETPress release

HCL Technologies (HCL), a leading global technology company, today presented its Wave Maker Awards 2020, commemorating global goodwill champions from around the world. The award ceremony, which was held at the HCL Pavilion in Davos, celebrated organizations and individuals passionately committed to such noble causes as diversity & inclusion, education & community upliftment, environment & sustainability, and technology for change. Special guest at the awards was Australian cricket legend Glenn McGrath, who is also founder of the McGrath Foundation, which provides support for Australian women diagnosed with breast cancer and their families. The award recipients were; Lois Auta, Founder and Executive Director of Cedar Seed Foundation, which supports persons with disabilities to participate in all aspects of life; Chido Govera, Founder and Director of The Future of Hope Foundation (TFoHF), which supports marginal and vulnerable members of society through entrepreneurial and self-developme

Ipsen’s palovarotene clinical program in fibrodysplasia ossificans progressiva reaches prespecified interim analysis futility criteria24.1.2020 09:00:00 EETPress release

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the decision to pause dosing patients in the global Phase III (PVO-1A-301) study designed to evaluate the efficacy and safety of palovarotene in patients with fibrodysplasia ossificans progressiva (FOP), as well as the ongoing Phase II (PVO-1A-202/204) extension studies. In both the Phase III and Phase II extension studies, palovarotene is dosed both chronically (daily) and episodically (during flare-ups). The decision to pause dosing patients in the trial is based on results of a futility analysis reviewed by the Independent Data Monitoring Committee (IDMC) as part of the prespecified interim analysis. The results of a futility analysis indicated that the Phase III FOP trial was unlikely to meet its primary efficacy endpoint (annualized change in new HO volume as compared with Natural History Studyi) upon completion. Despite the results of the prespecified interim analysis, signals of encouraging therapeutic activity w

Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos23.1.2020 23:56:00 EETPress release

Amazentis announces the debut of Timeline, a next generation nutrition product designed to promote healthy aging, as part of the Swiss Food & Nutrition Valley in the House of Switzerland at the World Economic Forum in Davos, Switzerland. Given the increase in the aging population globally -- according to a 2019 Deutsche Bank study, there are more people on Earth older than sixty five than younger than five for the first time -- it is imperative for consumers to take proactive measures to maintain a high quality of life, for as long as they live. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200123005820/en/ (Photo: Business Wire) Timeline contains the proprietary nutrient Mitopure™, a highly pure form of Urolithin A. After a decade of rigorous research by leading scientists around the world, Mitopure has been shown to help counter age-associated cellular and muscular decline by revitalizing the mitochondria, the powerplants

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom